GlaxoSmithKline (JOBS) Scales Back Relationship with Adolor Corporation

GlaxoSmithKline has returned to Adolor Corp. the worldwide rights related to the development of the Entereg drug for chronic opioid bowel dysfunction.

MORE ON THIS TOPIC